PEDF in diabetic retinopathy: A protective effect of oxidative stress

Journal of Biomedicine and Biotechnology

Volumn 2012, Issue , 2012, Pages

  Zhu, Xiao Feng ^a   Zou, Hai Dong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; ENDOTHELIAL NITRIC OXIDE SYNTHASE; JANUS KINASE 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN KINASE B; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; ANTIOXIDANT; EYE PROTEIN; NERVE GROWTH FACTOR; PIGMENT EPITHELIUM-DERIVED FACTOR; SERINE PROTEINASE INHIBITOR;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; DIABETIC RETINOPATHY; ENZYME ACTIVATION; GENE THERAPY; HUMAN; NONHUMAN; OXIDATIVE STRESS; PERICYTE; PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ANIMAL; METABOLISM; MOUSE;

ANIMALS; ANTIOXIDANTS; DIABETIC RETINOPATHY; EYE PROTEINS; HUMANS; MICE; NERVE GROWTH FACTORS; OXIDATIVE STRESS; SERPINS;

EID: 84861022044     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2012/580687     Document Type: Article

References (85)

1. Resnikoff S., Pascolini D., Etya'ale D., Kocur I., Pararajasegaram R., Pokharel G. P., Mariotti S. P., Global data on visual impairment in the year 2002 Bulletin of the World Health Organization 2004 82 11 844 851 (Pubitemid 39573742)
2. Kempen J. H., O'Colmain B. J., Leske M. C., Eye diseases prevalence research group. The prevalence of diabetic retinopathy among adults in the United States Archives of Ophthalmology 2004 122 4 552 563 (Pubitemid 38456292)
3. Saaddine J. B., Honeycutt A. A., Narayan K. M. V., Zhang X., Klein R., Boyle J. P., Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 20052050 Archives of Ophthalmology 2008 126 12 1740 1747
4. American Diabetes Association, Standards of medical care in diabetes2007 Diabetes Care 2007 30 supplement 1 S4 S41
5. Shamoon H., Duffy H., Fleischer N., Engel S., Saenger P., Strelzyn M., Litwak M., Wylie-Rosett J., Farkash A., Geiger D., Engel H., Fleischman J., Pompi D., Ginsberg N., Glover M., Brisman M., Walker E., Thomashunis A., Gonzalez J., The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus New England Journal of Medicine 1993 329 14 977 986 (Pubitemid 23307905)
6. Kowluru R. A., Kanwar M., Kennedy A., Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries Experimental Diabesity Research 2007 2007
7. Chan P. S., Kanwar M., Kowluru R. A., Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory Journal of Diabetes and its Complications 2010 24 1 55 63
8. Kowluru R. A., Effect of reinstitution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats Diabetes 2003 52 3 818 823 (Pubitemid 36323591)
9. Naruse K., Nakamura J., Hamada Y., Nakayama M., Chaya S., Komori T., Kato K., Kasuya Y., Miwa K., Naruse K., Hotta N., Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes Experimental Eye Research 2000 71 3 309 315
10. Geraldes P., Hiraoka-Yamamoto J., Matsumoto M., Clermont A., Leitges M., Marette A., Aiello L. P., Kern T. S., King G. L., Activation of PKC-and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy Nature Medicine 2009 15 11 1298 1306
11. Moore T. C. B., Moore J. E., Kaji Y., Frizzell N., Usui T., Poulaki V., Campbell I. L., Stitt A. W., Gardiner T. A., Archer D. B., Adamis A. P., The role of advanced glycation end products in retinal microvascular leukostasis Investigative Ophthalmology and Visual Science 2003 44 10 4457 4464 (Pubitemid 37186283)
12. Kline C. L. B., Schrufer T. L., Jefferson L. S., Kimball S. R., Glucosamine-induced phosphorylation of the -subunit of eukaryotic initiation factor 2 is mediated by the protein kinase R-like endoplasmic-reticulum associated kinase International Journal of Biochemistry and Cell Biology 2006 38 5-6 1004 1014 (Pubitemid 43363429)
13. Brownlee M., The pathobiology of diabetic complications: a unifying mechanism Diabetes 2005 54 6 1615 1625 (Pubitemid 40770750)
14. Marchioli R., Schweiger C., Levantesi G., Tavazzi L., Valagussa F., Antioxidant vitamins and prevention of cardiovascular disease: epidemiological and clinical trial data Lipids 2001 36 S53 S63
15. Dawson D. W., Volpert O. V., Gillis P., Crawford S. E., Xu H. J., Benedict W., Bouck N. P., Pigment epithelium-derived factor: a potent inhibitor of angiogenesis Science 1999 285 5425 245 248 (Pubitemid 29329995)
16. Spranger J., Osterhoff M., Reimann M., Mhlig M., Ristow M., Francis M. K., Cristofalo V., Hammes H. P., Smith G., Boulton M., Pfeiffer A. F. H., Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease Diabetes 2001 50 12 2641 2645 (Pubitemid 33733112)
17. Tombran-Tink J., Johnson L. V., Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells Investigative Ophthalmology and Visual Science 1989 30 8 1700 1707 (Pubitemid 19214990)
18. Ortego J., Escribano J., Becerra S. P., Coca-Prados M., Gene expression of the neurotrophic pigment epithelium-derived factor in the human ciliary epithelium: synthesis and secretion into the aqueous humor Investigative Ophthalmology and Visual Science 1996 37 13 2759 2767 (Pubitemid 27026562)
19. Becerra S. P., Sagasti A., Spinella P., Notario V., Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop Journal of Biological Chemistry 1995 270 43 25992 25999
20. Yabe T., Wilson D., Schwartz J. P., NF B Activation Is Required for the Neuroprotective Effects of Pigment Epithelium-derived Factor (PEDF) on Cerebellar Granule Neurons Journal of Biological Chemistry 2001 276 46 43313 43319
21. Liu H., Ren J. G., Cooper W. L., Hawkins C. E., Cowan M. R., Tong P. Y., Identification of the antivasopermeability effect of pigment epithelium-derived factor and its active site Proceedings of the National Academy of Sciences of the United States of America 2004 101 17 6605 6610 (Pubitemid 38586021)
22. Zhang S. X., Wang J. J., Gao G., Shao C., Mott R., Ma J. X., Pigment epithelium-derived factor (PEDF) is an endogenous antiinflammatory factor FASEB Journal 2006 20 2 323 325 (Pubitemid 46671158)
23. Matsuoka M., Ogata N., Otsuji T., Nishimura T., Takahashi K., Matsumura M., Expression of pigment epithelium derived factor and vascular endothelial growth factor in choroidal neovascular neovascular membranes and polypoidal choroidal vasculopathy British Journal of Ophthalmology 2004 88 6 809 815 (Pubitemid 38725593)
24. Yang H., Grossniklaus H. E., Constitutive overexpression of pigment epithelium-derived factor inhibition of ocular melanoma growth and metastasis Investigative Ophthalmology amp; Visual Science 2010 51 1 28 34
25. Yamagishi S. I., Inagaki Y., Amano S., Okamoto T., Takeuchi M., Makita Z., Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties Biochemical and Biophysical Research Communications 2002 296 4 877 882
26. Yoshida Y., Yamagishi S. I., Matsui T., Jinnouchi Y., Fukami K., Imaizumi T., Yamakawa R., Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy Diabetes/Metabolism Research and Reviews 2009 25 7 678 686
27. Yamagishi S. I., Inagaki Y., Nakamura K., Abe R., Shimizu T., Yoshimura A., Imaizumi T., Pigment epithelium-derived factor inhibits TNF- -induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation Journal of Molecular and Cellular Cardiology 2004 37 2 497 506 (Pubitemid 38953377)
28. Nakamura K., Yamagishi S. I., Matsui T., Yoshida T., Takenaka K., Jinnouchi Y., Yoshida Y., Ueda S. I., Adachi H., Imaizumi T., Pigment epithelium-derived factor inhibits neointimal hyperplasia after vascular injury by blocking NADPH oxidase-mediated reactive oxygen species generation American Journal of Pathology 2007 170 6 2159 2170 (Pubitemid 47339287)
29. Ogata N., Tombran-Tink J., Nishikawa M., Nishimura T., Mitsuma Y., Sakamoto T., Matsumura M., Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment American Journal of Ophthalmology 2001 132 3 378 382 (Pubitemid 32768607)
30. Boehm B. O., Lang G., Feldmann B., Kurkhaus A., Rosinger S., Volpert O., Lang G. K., Bouck N., Proliferative diabetic retinopathy is associated with a low level of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor. A pilot study Hormone and Metabolic Research 2003 35 6 382 386 (Pubitemid 37102685)
31. Boehm B. O., Lang G., Volpert O., Jehle P. M., Kurkhaus A., Rosinger S., Lang G. K., Bouck N., Low content of the natural ocular anti-angiogenic agent pigment epithelium-derived factor (PEDF) in aqueous humor predicts progression of diabetic retinopathy Diabetologia 2003 46 3 394 400 (Pubitemid 36547595)
32. Ogata N., Matsuoka M., Matsuyama K., Shima C., Tajika A., Nishiyama T., Wada M., Jo N., Higuchi A., Minamino K., Matsunaga H., Takeda T., Matsumura M., Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy Journal of Clinical Endocrinology and Metabolism 2007 92 3 1176 1179 (Pubitemid 46465700)
33. Cohen M. P., Hud E., Shea E., Shearman C. W., Vitreous fluid of db/db mice exhibits alterations in angiogenic and metabolic factors consistent with early diabetic retinopathy Ophthalmic Research 2007 40 1 5 9 (Pubitemid 350308296)
34. Notari L., Miller A., Martnez A., Amaral J., Ju M., Robinson G., Smith L. E. H., Becerra S. P., Pigment epithelium-derived factor is a substrate for matrix metalloproteinase type 2 and type 9: implications for downregulation in hypoxia Investigative Ophthalmology and Visual Science 2005 46 8 2736 2747 (Pubitemid 43086693)
35. Stellmach V., Crawford S. E., Zhou W., Bouck N., Prevention of ischemia-induced retinopathy by the natural ocular antiangiogenic agent pigment epithelium-derived factor Proceedings of the National Academy of Sciences of the United States of America 2001 98 5 2593 2597 (Pubitemid 32209527)
36. Yamagishi S. I., Matsui T., Nakamura K., Yoshida T., Takeuchi M., Inoue H., Yoshida Y., Imaizumi T., Pigment-epithelium-derived factor suppresses expression of receptor for advanced glycation end products in the eye of diabetic rats Ophthalmic Research 2007 39 2 92 97 (Pubitemid 46909866)
37. Katakami N., Kaneto H., Yamasaki Y., Matsuhisa M., Increased serum pigment epithelium-derived factor levels in type 1 diabetic patients with diabetic retinopathy Diabetes Research and Clinical Practice 2008 81 1 e4 e7
38. Yoshida Y., Yamagishi S. I., Matsui T., Nakamura K., Imaizumi T., Yoshimura K., Yamakawa R., Positive correlation of pigment epithelium-derived factor and total antioxidant capacity in aqueous humour of patients with uveitis and proliferative diabetic retinopathy British Journal of Ophthalmology 2007 91 9 1133 1134 (Pubitemid 47344883)
39. Wang J. J., Zhang S. X., Mott R., Knapp R. R., Cao W., Lau K., Ma J. X., Salutary effect of pigment epithelium-derived factor in diabetic nephropathy: evidence for antifibrogenic activities Diabetes 2006 55 6 1678 1685 (Pubitemid 44324120)
40. Duh E. J., Yang H. S., Suzuma I., Miyagi M., Youngman E., Mori K., Katai M., Yan L., Suzuma K., West K., Davarya S., Tong P., Gehlbach P., Pearlman J., Crabb J. W., Aiello L. P., Campochiaro P. A., Zack D. J., Pigment epithelium-derived factor suppresses ischemia-induced retinal neovascularization and VEGF-induced migration and growth Investigative Ophthalmology and Visual Science 2002 43 3 821 829 (Pubitemid 34184503)
41. Gurunathan S., Duh E., PEDF inhibits VEGF activation of PI3 Kinase/ Akt and Src in human retinal endothelial cells Investigative Ophthalmology and Visual Science 2005 46
42. Hutchings H., Maitre-Boube M., Tombran-Tink J., Plouta J., Pigment epithelium-derived factor exerts opposite effects on endothelial cells of different phenotypes Biochemical and Biophysical Research Communications 2002 294 4 764 769 (Pubitemid 34687182)
43. Mu H., Zhang X. M., Liu J. J., Dong L., Feng Z. L., Effect of high glucose concentration on VEGF and PEDF expression in cultured retinal Mller cells Molecular Biology Reports 2009 36 8 2147 2151
44. Yamagishi S. I., Hsu C. C., Taniguchi M., Harada S., Yamamoto Y., Ohsawa K. S., Kobayashi K. I., Yamamoto H., Receptor-mediated toxicity to pericytes of advanced glycosylation end products: a possible mechanism of pericyte loss in diabetic microangiopathy Biochemical and Biophysical Research Communications 1995 213 2 681 687
45. Yamagishi S. I., Amano S., Inagaki Y., Okamoto T., Koga K., Sasaki N., Yamamoto H., Takeuchi M., Makita Z., Advanced glycation end products-induced apoptosis and overexpression of vascular endothelial growth factor in bovine retinal pericytes Biochemical and Biophysical Research Communications 2002 290 3 973 978 (Pubitemid 34687457)
46. Yamagishi S., Matsui T., Inoue H., Inhibition by advanced glycation end products (AGEs) of pigment epithelium-derived factor (PEDF) gene expression in microvascular endothelial cells Drugs under Experimental and Clinical Research 2005 31 5-6 227 232 (Pubitemid 43052037)
47. Mandarino L. J., Current hypotheses for the biochemical basis of diabetic retinopathy Diabetes Care 1992 15 12 1892 1901
48. Frank R. N., On the pathogenesis of diabetic retinopathy: a 1990 update Ophthalmology 1991 98 5 586 593
49. Amano S., Yamagishi S. I., Inagaki Y., Nakamura K., Takeuchi M., Inoue H., Imaizumi T., Pigment epithelium-derived factor inhibits oxidative stress-induced apoptosis and dysfunction of cultured retinal pericytes Microvascular Research 2005 69 1-2 45 55 (Pubitemid 40410467)
50. Inagaki Y., Yamagishi S., Okamoto T., Takeuchi M., Amano S., Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation Diabetologia 2003 46 2 284 287 (Pubitemid 36343893)
51. Mitamura Y., Takeuchi S., Matsuda A., Tagawa Y., Mizue Y., Nishihira J., Monocyte chemotactic protein-1 in the vitreous of patients with proliferative diabetic retinopathy Ophthalmologica 2001 215 6 415 418 (Pubitemid 34008787)
52. Stitt A. W., The role of advanced glycation in the pathogenesis of diabetic retinopathy Experimental and Molecular Pathology 2003 75 1 95 108 (Pubitemid 36798117)
53. Yamagishi S. I., Inagaki Y., Amano S., Okamoto T., Takeuchi M., Makita Z., Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties Biochemical and Biophysical Research Communications 2002 296 4 877 882
54. Okamoto T., Yamagishi S. I., Inagaki Y., Amano S., Koga K., Abe R., Takeuchi M., Ohno S., Yoshimura A., Makita Z., Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin The FASEB Journal 2002 16 14 1928 1930
55. Yamagishi S. I., Ueda S., Matsui T., Nakamura K., Imaizumi T., Takeuchi M., Okuda S., Pigment Epithelium-Derived Factor (PEDF) prevents Advanced Glycation End products (AGEs)-elicited endothelial Nitric Oxide Synthase (eNOS) reduction through its anti-oxidative properties Protein and Peptide Letters 2007 14 8 832 835 (Pubitemid 47416409)
56. Victor V. M., Rocha M., Targeting antioxidants to mitochondria: a potential new therapeutic strategy for cardiovascular diseases Current Pharmaceutical Design 2007 13 8 845 863 (Pubitemid 46585507)
57. Sudano I., Spieker L. E., Hermann F., Flammer A., Corti R., Noll G., Lscher T. F., Protection of endothelial function: targets for nutritional and pharmacological interventions Journal of Cardiovascular Pharmacology 2006 47 2 S136 S150
58. Yamagishi S. I., Nakamura K., Matsui T., Ueda S. I., Imaizumi T., Role of postprandial hyperglycaemia in cardiovascular disease in diabetes International Journal of Clinical Practice 2007 61 1 83 87
59. Takenaka K., Yamagishi S. I., Matsui T., Nakamura K., Imaizumi T., Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes Current Neurovascular Research 2006 3 1 73 77
60. Yamagishi S. I., Edelstein D., Du X. L., Brownlee M., Hyperglycemia potentiates collagen-induced platelet activation through mitochondrial superoxide overproduction Diabetes 2001 50 6 1491 1494 (Pubitemid 32500184)
61. Yamagishi S. I., Matsui T., Takenaka K., Nakamura K., Takeuchi M., Inoue H., Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs) Diabetes/Metabolism Research and Reviews 2009 25 3 266 271
62. Sheikpranbabu S., Haribalaganesh R., Gurunathan S., Pigment epithelium-derived factor inhibits advanced glycation end-products-induced cytotoxicity in retinal pericytes Diabetes and Metabolism 2011 37 6 505 511
63. Sheikpranbabu S., Haribalaganesh R., Banumathi E., Sirishkumar N., Lee K. J., Gurunathan S., Pigment epithelium-derived factor inhibits advanced glycation end-product-induced angiogenesis and stimulates apoptosis in retinal endothelial cells Life Sciences 2009 85 21-22 719 731
64. Yamagishi S. I., Amano S., Inagaki Y., Okamoto T., Takeuchi M., Inoue H., Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties Microvascular Research 2003 65 3 186 190 (Pubitemid 36438684)
65. Gariano R. F., Nath A. K., D'Amico D. J., Lee T., Sierra-Honigmann M. R., Elevation of vitreous leptin in diabetic retinopathy and retinal detachment Investigative Ophthalmology and Visual Science 2000 41 11 3576 3581
66. Yamagishi S. I., Inagaki Y., Nakamura K., Abe R., Shimizu T., Yoshimura A., Imaizumi T., Pigment epithelium-derived factor inhibits TNF- -induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation Journal of Molecular and Cellular Cardiology 2004 37 2 497 506 (Pubitemid 38953377)
67. Berghe W. V., Vermeulen L., De Wilde G., De Bosscher K., Boone E., Haegeman G., Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6 Biochemical Pharmacology 2000 60 8 1185 1195
68. Li J. M., Mullen A. M., Yun S., Wientjes F., Brouns G. Y., Thrasher A. J., Shah A. M., Essential role of the NADPH oxidase subunit p47phox in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor- Circulation Research 2002 90 2 143 150 (Pubitemid 34627082)
69. Yamagishi S. I., Nakamura K., Ueda S., Kato S., Imaizumi T., Pigment epithelium-derived factor (PEDF) blocks angiotensin II signaling in endothelial cells via suppression of NADPH oxidase: a novel anti-oxidative mechanism of PEDF Cell and Tissue Research 2005 320 3 437 445 (Pubitemid 40884145)
70. Yamagishi S. I., Matsui T., Nakamura K., Inoue H., Pigment epithelium-derived factor is a pericyte mitogen secreted by microvascular endothelial cells: possible participation of angiotensin II-elicited PEDF downregulation in diabetic retinopathy International Journal of Tissue Reactions 2005 27 4 197 202 (Pubitemid 43056221)
71. Lu M., Adamis A. P., Vascular endothelial growth factor gene regulation and action in diabetic retinopathy Ophthalmology Clinics of North America 2002 15 1 69 79 (Pubitemid 34579204)
72. Zhang S. X., Wang J. J., Dashti A., Wilson K., Zou M. H., Szweda L., Ma J. X., Lyons T. J., Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein Journal of Molecular Endocrinology 2008 41 3-4 135 143
73. Zheng Z., Chen H., Ke G., Fan Y., Zou H., Sun X., Gu Q., Xu N., Ho P. C. P., Protective effect of perindopril on diabetic retinopathy is associated with decreased vascular endothelial growth factor-to-pigment epithelium-derived factor ratio: involvement of a mitochondria-reactive oxygen species pathway Diabetes 2009 58 4 954 964
74. Zheng Z., Chen H., Zhao H., Liu K., Luo D., Chen Y., Chen Y., Yang X., Gu Q., Xu X., Inhibition of JAK2/STAT3-mediated VEGF upregulation under high glucose conditions by PEDF through a mitochondrial ROS pathway in vitro Investigative Ophthalmology amp; Visual Science 2010 51 1 64 71
75. Yokoi M., Yamagishi S. I., Saito A., Yoshida Y., Matsui T., Saito W., Hirose S., Ohgami K., Kase M., Ohno S., Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy British Journal of Ophthalmology 2007 91 7 885 887 (Pubitemid 47013096)
76. Yamagishi S. I., Nakamura K., Matsui T., Inagaki Y., Takenaka K., Jinnouchi Y., Yoshida Y., Matsuura T., Narama I., Motomiya Y., Takeuchi M., Inoue H., Yoshimura A., Bucala R., Imaizumi T., Pigment epithelium-derived factor inhibits advanced glycation end product-induced retinal vascular hyperpermeability by blocking reactive oxygen species-mediated vascular endothelial growth factor expression Journal of Biological Chemistry 2006 281 29 20213 20220 (Pubitemid 44065796)
77. Banumathi E., Sheikpranbabu S., Haribalaganesh R., Gurunathan S., PEDF prevents reactive oxygen species generation and retinal endothelial cell damage at high glucose levels Experimental Eye Research 2010 90 1 89 96
78. Anderson O. A., Bainbridge J. W. B., Shima D. T., Delivery of anti-angiogenic molecular therapies for retinal disease Drug Discovery Today 2010 15 7-8 272 282
79. Longeras R., Ma J.-X., Farjo K., Ihnat M., A PEDF-derived peptide inhibits retinal neovascularization and blocks mobilization of bone marrow-derived endothelial progenitor cells Experimental Diabetes Research 2012 2012 11
80. Herrero-Vanrell R., Refojo M. F., Biodegradable microspheres for vitreoretinal drug delivery Advanced Drug Delivery Reviews 2001 52 1 5 16 (Pubitemid 32973634)
81. Yeh M. K., Tung S. M., Lu D. W., Chen J. L., Chiang C. H., Formulation factors for preparing ocular biodegradable delivery system of 5-fluorouracil microparticles Journal of Microencapsulation 2001 18 4 507 519
82. Li H., Tran V. V., Hu Y., Mark Saltzman W., Barnstable C. J., Tombran-Tink J., A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres Experimental Eye Research 2006 83 4 824 833 (Pubitemid 44292678)
83. Giordano G. G., Chevez-Barrios P., Refojo M. F., Garcia C. A., Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic)acid microspheres Current Eye Research 1995 14 9 761 768
84. Campochiaro P. A., Nguyen Q. D., Shah S. M., Klein M. L., Holz E., Frank R. N., Saperstein D. A., Gupta A., Stout J. T., Macko J., DiBartolomeo R., Wei L. L., Adenoviral vector-delivered pigment epithelium-derived factor for neovascular age-related macular degeneration: results of a phase I clinical trial Human Gene Therapy 2006 17 2 167 176 (Pubitemid 43262032)
85. Park K., Jin J., Hu Y., Zhou K., Ma J.-X., Overexpression of pigment epithelium-derived factor inhibits retinal inflammation and neovascularization American Journal of Pathology 2011 178 2 688 698